Trinity Capital Valuation

Is 9F7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 9F7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 9F7 (€14.01) is trading below our estimate of fair value (€35.48)

Significantly Below Fair Value: 9F7 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 9F7?

Key metric: As 9F7 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 9F7. This is calculated by dividing 9F7's market cap by their current earnings.
What is 9F7's PE Ratio?
PE Ratio9.8x
EarningsUS$87.44m
Market CapUS$852.96m

Price to Earnings Ratio vs Peers

How does 9F7's PE Ratio compare to its peers?

The above table shows the PE ratio for 9F7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average8.2x
MLP MLP
10x8.3%€644.9m
AR4 AURELIUS Equity Opportunities SE KGaA
3.9xn/a€394.9m
HXCK Ernst Russ
3.6x-18.2%€190.7m
O4B OVB Holding
15.3x3.5%€283.6m
9F7 Trinity Capital
9.8x21.3%€853.0m

Price-To-Earnings vs Peers: 9F7 is expensive based on its Price-To-Earnings Ratio (9.8x) compared to the peer average (8.2x).


Price to Earnings Ratio vs Industry

How does 9F7's PE Ratio compare vs other companies in the DE Capital Markets Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
AR4 AURELIUS Equity Opportunities SE KGaA
3.9xn/aUS$416.78m
HXCK Ernst Russ
3.6x-18.2%US$201.25m
VG8 Varengold Bank
2xn/aUS$25.65m
XE8 Black Sea Property
0.7xn/aUS$7.78m
No more companies available in this PE range
9F7 9.8xIndustry Avg. 20.3xNo. of Companies6PE01632486480+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 9F7 is good value based on its Price-To-Earnings Ratio (9.8x) compared to the German Capital Markets industry average (20.3x).


Price to Earnings Ratio vs Fair Ratio

What is 9F7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9F7 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.8x
Fair PE Ratio15.4x

Price-To-Earnings vs Fair Ratio: 9F7 is good value based on its Price-To-Earnings Ratio (9.8x) compared to the estimated Fair Price-To-Earnings Ratio (15.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 9F7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€14.01
€14.88
+6.2%
7.5%€16.23€12.41n/a8
Nov ’25€12.35
€14.25
+15.4%
7.4%€15.63€11.95n/a8
Oct ’25€12.04
€13.96
+16.0%
5.7%€15.19€12.51n/a8
Sep ’25€12.51
€13.96
+11.6%
5.7%€15.19€12.51n/a8
Aug ’25€13.31
€14.36
+7.9%
6.3%€15.63€12.87n/a8
Jul ’25€13.00
€14.51
+11.6%
5.9%€15.85€13.05n/a8
Jun ’25€13.97
€14.51
+3.8%
5.9%€15.85€13.05n/a8
May ’25€13.95
€14.61
+4.8%
6.1%€15.90€13.09n/a8
Apr ’25€13.40
€14.41
+7.5%
5.9%€15.61€12.86n/a8
Mar ’25€13.30
€14.26
+7.2%
5.6%€15.64€12.88n/a8
Feb ’25€12.90
€14.26
+10.5%
5.6%€15.64€12.88n/a8
Jan ’25€13.20
€14.59
+10.6%
5.4%€15.94€13.13n/a8
Dec ’24€13.30
€14.59
+9.7%
5.4%€15.94€13.13n/a8
Nov ’24€12.80
€14.35
+12.1%
5.4%€15.67€12.91€12.358
Oct ’24€13.20
€14.35
+8.7%
5.4%€15.67€12.91€12.048
Sep ’24€13.30
€14.35
+7.9%
5.4%€15.67€12.91€12.518
Aug ’24€13.10
€13.00
-0.7%
9.4%€14.57€11.15€13.318
Jul ’24€12.10
€12.00
-0.8%
11.5%€13.93€10.21€13.007
Jun ’24€11.70
€12.00
+2.6%
11.5%€13.93€10.21€13.977
May ’24€10.80
€12.57
+16.3%
12.5%€14.58€10.03€13.957
Apr ’24€11.70
€12.91
+10.4%
11.8%€14.91€10.25€13.407
Mar ’24€12.40
€12.32
-0.7%
7.0%€13.98€11.19€13.307
Feb ’24€12.20
€11.83
-3.1%
11.3%€13.80€9.20€12.907
Jan ’24€10.10
€13.22
+30.9%
22.0%€19.31€9.42€13.207
Dec ’23€10.20
€12.40
+21.5%
12.5%€14.42€9.62€13.307
Nov ’23€11.80
€15.66
+32.7%
13.2%€18.06€12.80€12.807

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies